Global Lifescience Reagent Market to surpass US$ 63.5 billion by 2026 – Coherent Market Insights

SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BiochemicalReagents?src=hash" target="_blank"gt;#BiochemicalReagentslt;/agt;–According to Coherent Market Insights, the global Lifescience Reagent
Market was valued at US$ 33,754.0 million in 2017 and is projected to
exhibit a CAGR of 7.3% during the forecast period (2018–2026).

Key Trends and Analysis of the Global Lifescience Reagent Market:

Manufacturers are engaged in developing biological reagents for various
research purposes, which is expected to drive the global lifescience
reagents market growth. For instance, in June 2014, Bio-Rad
laboratories, Inc. launched SsoAdvanced Preamp Supermix and Primepcr
Preamp Assays. The new reagent, ssoadvanced preamp supermix, has been
formulated to permit unbiased, target-specific preamplification of cDNA
or genomic DNA (gDNA), allowing researchers to stretch their limited
nucleic acid samples. Primepcr PreAmp assays are wet-lab validated
preamplification primers that work with the supermix to ensure optimal
preamplification for real-time polymerase chain reaction (PCR)

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2681

Moreover, in April 2019, Quantabio launched the Qscript lyo 1-step, a
lyophilized single-reaction reagent, optimized for highly sensitive and
reproducible RT-qPCR RNA applications. The freeze-dried Qscript lyo
1-step master can be stored up to nine months at ambient temperatures or
two years at 4 degrees Celsius from the manufacturing date. Moreover, in
February 2019, Thermo Fisher Scientific launched its CytoVista tissue
clearing reagents, which are designed for use with both 3D cell culture
models as well as whole tissues. The CytoVista tissue clearing
technology sufficiently clears tissue for 3D fluorescent imaging.

Increasing acquisitions among the biotechnology industry players is
contributing to global lifescience reagent market share. For instance,
in February 2017, Anatrace (StoneCalibre’s portfolio company), acquired
Molecular Dimensions Ltd. Molecular Dimensions Ltd is the U.K.-based
supplier of modern screens, reagents, and other consumables and
instrumentation for structural biology research. With this acquisition,
Anatrace intended to establish its presence in Europe and expand its
position in the structural biology product portfolio.

Europe is expected to show significant market growth rate, owing to
increasing initiatives by the key players in this region. For instance,
in 2014, Biofortuna, a U.K.-based provider of high quality IVD
development and custom manufacturing services, expanded its PCR reagent
lyophilization production service to meet increasing demand for
diagnostic kits containing freeze-dried reagents in the emerging market.

To know the latest trends and insights prevalent in this market,
click the link below:

https://www.coherentmarketinsights.com/market-insight/lifescience-reagent-market-2681

Key Market Takeaways:

• The global lifescience reagent market is projected to witness CAGR of
  7.3% during the forecast period (2018–2026), owing to increasing
  product launches of lifescience reagents. For instance, in October
  2017, Sysmex America Inc. launched CyFlow Antibodies, a comprehensive
  portfolio of Analyte Specific Reagent (ASR) antibodies for the use in
  flow cytometry applications. It boasts monoclonal antibodies with high
  Mean Fluorescent Intensity (MFI) and dependable lot-to-lot consistency.
• Among region, North America is expected to show significant growth in
  global lifescience reagent market, owing to increasing initiatives by
  key players involved in lifescience research purpose. For instance, in
  May 2017, Avacta gave exclusive rights to two U.S-based biotech
  companies (names not disclosed) to use Affimer reagents for research
  and development purpose, which supports their respective drug
  development programs. Affimer reagents were developed by the Avacta.
• Major players operating in the global lifescience reagent market
  include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott
  Laboratories, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Siemens
  Healthineers, Becton, Dickinson and Company, Agilent Technologies
  Inc., Perkin Elmer Inc., Waters Corporation, Ortho Clinical
  Diagnostics, bioMérieux SA, and Sysmex Corporation

Buy this exclusive Business report now @ https://www.coherentmarketinsights.com/insight/buy-now/2681

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting
firm offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.

Contacts

Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle,
WA 98154
Tel: +1-206-701-6702
Email: [email protected]